Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 9 of 378 for:    LENALIDOMIDE AND Dexamethasone

Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03283046
Recruitment Status : Withdrawn (Similar to another study.)
First Posted : September 14, 2017
Last Update Posted : September 20, 2017
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2020